微RNA-146a在癌症发育中的作用通过调节亡来调节癌症
Keihan Kookli1, Kosar Torfi Soleimani2, Eman Fathy Amr3
1International Campus, Iran University of Medical Sciences, Tehran, Iran.
Pathology, research and practice
|January 10, 2024
概括
像miR-146a这样的微RNA (miRNA) 在癌症发育和细胞死亡中至关重要. 了解miR-146a的使用情况
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 癌症仍然是一个重大的全球健康挑战,尽管治疗方面取得了进展.
- 微RNAs (miRNAs) 是调节基因表达的小型非编码RNAs,在癌症中经常失调.
- 在瘤中,MiR-146a经常过度表达,并与癌细胞亡和进展有关.
研究的目的:
- 探索miR-146a在调节癌细胞亡中的作用.
- 研究miR-146a作为治疗癌症治疗的治疗点的潜力.
- 审查miR-146a在癌细胞死亡和化疗耐药性的生物发生,功能和影响.
主要方法:
- 关于miR-146a,癌症和亡的研究的文献综述.
- 对miR-146a在各种细胞死亡途径中的参与进行分析.
- 对外体miR-146a对癌细胞亡的影响的研究.
主要成果:
- MiR-146a的表达与癌细胞中的病理变化和亡调节有关.
- 调节miRNA表达,包括miR-146a,在缓解癌症方面显示出希望.
- 外体miR-146a可能会促进细胞亡,并可能克服化疗耐药性.
结论:
- MiR-146a在癌细胞的亡和进展中起着重要作用.
- 向miR-146a为改善癌症治疗结果提供了一个有希望的策略.
- 对外体miR-146a的进一步研究可能会导致对抗癌症和耐药性的新方法.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


